| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | CELGENE CORP | 135,000 | 13,512,000 | 14.00% | ||
| 2 | SHIRE PLC | 76,200 | 13,099,000 | 13.57% | ||
| 3 | PFIZER INC | 436,000 | 12,923,000 | 13.39% | ||
| 4 | ALLERGAN PLC | 27,500 | 7,371,000 | 7.64% | ||
| 5 | BRISTOL MYERS SQUIBB CO | 101,000 | 6,452,000 | 6.68% | ||
| 6 | MYLAN N V | 136,000 | 6,304,000 | 6.53% | ||
| 7 | SANOFI | 117,000 | 4,699,000 | 4.87% | ||
| 8 | HORIZON PHARMA PLC | 220,000 | 3,645,000 | 3.78% | ||
| 9 | SEATTLE GENETICS INC | 103,000 | 3,614,000 | 3.74% | ||
| 10 | LANNET INC COM NEW | 150,000 | 2,690,000 | 2.79% | ||
| 11 | CONCERT PHARMACEUTICALS INC COM | 183,000 | 2,500,000 | 2.59% | ||
| 12 | Exelexis | 2,000,000 | 1,991,000 | 2.06% | PRN | |
| 13 | IMMUNOGEN INCORPORATED | 228,000 | 1,943,000 | 2.01% | ||
| 14 | ADAMAS PHARMACEUTICALS INC | 117,000 | 1,692,000 | 1.75% | ||
| 15 | NEUROCRINE BIOSCIE COM USD0.001 | 42,000 | 1,661,000 | 1.72% | ||
| 16 | UNIQURE NV | 115,000 | 1,366,000 | 1.41% | ||
| 17 | EAGLE PHARMACEUTICALS INC COM | 33,000 | 1,337,000 | 1.38% | Put | |
| 18 | IMMUNE DESIGN CORP COM | 85,138 | 1,107,000 | 1.15% | ||
| 19 | IGNYTA INC COM | 150,000 | 1,016,000 | 1.05% | ||
| 20 | NEURODERM LTD | 70,000 | 988,000 | 1.02% | ||
| 21 | ADVAXIS INC COM NEW | 100,000 | 903,000 | 0.94% | ||
| 22 | FIVE PRIME THERAPEUTICS INC | 20,000 | 813,000 | 0.84% | ||
| 23 | Lion Biotechnologies | 152,266 | 774,000 | 0.80% | ||
| 24 | INFINITY PHARMACEUTICALS INC COM | 145,000 | 764,000 | 0.79% | ||
| 25 | AERIE PHARMACEUTICALS INC | 60,280 | 733,000 | 0.76% | ||
| 26 | INSMED INC COM PAR .01 | 40,000 | 507,000 | 0.53% | ||
| 27 | PROGENICS PHARMACEUTICALS IN | 96,000 | 419,000 | 0.43% | ||
| 28 | CYNAPSUS THERAPEUTICS INC | 33,716 | 401,000 | 0.42% | ||
| 29 | BIOPHARMX CORP COM | 345,440 | 377,000 | 0.39% | ||
| 30 | TOBIRA THERAPEUTICS INC | 45,000 | 368,000 | 0.38% | ||
| 31 | XENOPORT INC | 80,000 | 361,000 | 0.37% | ||
| 32 | MINERVA NEUROSCIENCES INC COM | 34,100 | 209,000 | 0.22% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-16-064987, filed 2016.05.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
